ABBOTINDIA: Revenue and profit rose year-over-year, with strong EPS growth and clean auditor review

About this update from Abbott India Limited

Revenue and net profit grew year-over-year for the quarter ended June 30, 2025, with EPS also rising. Auditors found no material misstatements, and the company continues to operate solely in the pharmaceuticals segment.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Abbott India Limited